Patent Assignment
Reel/Frame 063233/0605
Assignment of Assignor's Interest
Recorded: 2023-04-05
Pages: 6
Assignor
MADDEN, STUART
Executed: 2023-04-04
Assignee
NEURELIS, INC.
3430 CARMEL MOUNTAIN ROAD, SUITE 300, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Intranasal Olanzapine Formulations and Methods of Their Use
Patent:
12,171,868 →
Application:
18/125,940 →
Publication:
US 2023/0301903
PCT:
PCT/US2023/016204 ↗
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jun 4, 2023
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 063848/0209 →
Release of Security Interest
Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →